HRAS Antibody

Polyclonal Antibody

HRAS

C BAS/HAS antibody, C HA RAS1 antibody, C-BAS/HAS antibody, c-H-ras antibody, C-HA-RAS1 antibody, CTLO antibody, GTPase HRas antibody, GTPase KRas antibody, GTPase NRas antibody, H ras antibody, H RASIDX antibody, H-Ras-1 antibody, H-RASIDX antibody, Ha-Ras antibody, HAMSV antibody, HRAS antibody, HRAS1 antibody, K ras antibody, K RAS2A antibody, K RAS2B antibody, K RAS4A antibody, K RAS4B antibody, K-RAS antibody, KRAS antibody, KRAS1 antibody, KRAS2 antibody, N-RAS antibody, N-terminally processed antibody, NRAS antibody, NRAS1 antibody, p21ras antibody, RASH_HUMAN antibody, RASH1 antibody, RASK2 antibody, Transforming protein p21 antibody, v Ha ras Harvey rat sarcoma viral oncogene homolog antibody, v Ki ras2 Kirsten rat sarcoma viral oncogene homolog antibody, v ras neuroblastoma RAS viral oncogene homolog antibody

Synthetic peptide of human HRAS

This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, mental retardation, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene.

Antigen Affinity Purified

Signal Transduction

Synthetic peptide of Human HRAS